Weil v. Fritz

572 F.2d 856, 196 U.S.P.Q. (BNA) 600, 1978 CCPA LEXIS 342
CourtCourt of Customs and Patent Appeals
DecidedJanuary 26, 1978
DocketAppeal No. 77-557
StatusPublished
Cited by15 cases

This text of 572 F.2d 856 (Weil v. Fritz) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Weil v. Fritz, 572 F.2d 856, 196 U.S.P.Q. (BNA) 600, 1978 CCPA LEXIS 342 (ccpa 1978).

Opinion

BALDWIN, Judge.

This is an appeal by Weil,1 the junior party, from the decision of the Patent and Trademark Office Board of Patent Interferences (board) which awarded priority of invention to Fritz et al. (Fritz),2 ruling that Fritz was entitled to the benefit of an earlier application with a filing date before the earliest date asserted by Weil, his filing date. We reverse and remand.

Background

The subject matter of the interference is defined by the sole count which reads as follows:

A method for the inhibition of plant growth which comprises applying thereto an effective amount of 2 — chloroethylphosphonic acid [hereafter 2-CEPA].3

The chronology of applications is as follows:

Party Fritz Party Weil
Application Serial No. 617,860 (hereafter Fritz I) filed February 23,1967; abandoned December 1,1969 applicants: Fritz and Evans
Application Serial No. 693,698 (hereafter Fritz II) filed December 27,1967; abandoned April 2,1970 continuation-in-part of Fritz I applicants: Fritz and Evans (amendment approved March 27, 1970 adding Cooke as joint inventor
Application Serial No. 826,663 filed May 21, 1969
Application Serial No. 869,386 (hereafter Fritz III) filed October 24, 1969 continuation-in-part of Fritz II applicants: Fritz, Evans, and Cooke
Application Serial No. 221,803 (Fritz IV) filed January 28,1972 division of Fritz III applicants: Fritz, Evans, and Cooke

The interference was declared on September 7, 1971, between Weil and Fritz III. In the declaration of interference, the patent interference examiner accorded Fritz III the benefit of Fritz I and II, making Weil the junior party. Fritz thereafter filed Fritz IV and moved to substitute Fritz IV for Fritz III.

Weil moved to shift the burden of proof,4 i. e., to deny Fritz III the benefit of the filing dates of Fritz I and II under 37 CFR 1.231(a)(4),5 on the ground that Fritz I and II “are not consistent regarding inventor-ship with the later-filed application [Fritz III].”

The primary examiner granted Fritz’s motion to substitute Fritz IV, awarding that application the benefit of Fritz I, II, and III, and denied Weil’s motion to shift the burden of proof, ruling that Fritz IV was entitled to the earlier dates under 35 U.S.C. § 1206 because the inventorship in [859]*859Fritz II had been properly corrected under 35 U.S.C. § 116.7 The primary examiner cited In re Schmidt, 293 F.2d 274, 48 CCPA 1140, 130 USPQ 404 (1961), as “completely apposite here.”

Weil petitioned the Commissioner to review the action of the primary examiner in refusing to shift the burden of proof. The Commissioner, denying Weil’s petition, stated: “The question of burden of proof is ancillary to priority and is reviewable at final hearing by the Board of Patent Interferences, and in the courts if desired.”

Weil petitioned this court for a writ of mandamus ordering the Commissioner to grant the motion to shift the burden of proof. We denied that petition. Weil v. Dann, 503 F.2d 562, 183 USPQ 300 (Cust. & Pat.App.1974).

Fritz, the senior party, then took testimony-in-chief and Weil took rebuttal testimony. After Fritz’s testimony-in-chief, Weil filed a second motion to deny Fritz IV the benefit of the filing dates of Fritz I and II on the following basis:

Testimony adduced from witnesses of the party Fritz et al., during its testimony-in-chief, has revealed, for the first time in this interference, that:
1. Long prior to the filing of the earliest of the aforementioned applications, Fritz et al contemplated a preferred mode of carrying out the method of the count;
2. The said preferred mode was the best mode contemplated by Fritz et al for carrying out the invention defined by the count; and
3. Notwithstanding the mandate of 35 U.S.C. § 112, first paragraph8, Fritz et al did not disclose the best mode known to them in either of the aforementioned applications. [Footnote omitted.]
******
The count * * * pertains to a method of inhibiting plant growth by applying 2-chloroethylphosphonic acid [2-CEPA], * * *
The [2-CEPA] is soluble in water and is normally applied to the plants in the form of an aqueous solution. * * *
******
The testimony reveals that by no later than the end of 1965, the party Fritz et al and others at Amchem regarded the 2-chloroethylphosphonic acid to be unstable and susceptible to decomposition when contained in water solution having a pH greater than about 4.5. The evidence [860]*860further shows Fritz et al contemplated that the application of the acid material to plants in water solution is preferably effected under certain operating conditions to prevent or avoid the detrimental effects of such decomposition. [Footnote omitted.]
Specifically, it was contemplated by Fritz et al that solution conditions be used which would maintain the pH below about 4.5 and/or that a spray or application solution of 2-chloroethylphosphonic acid be applied to the plants promptly after formulating the spray solution, particularly if the solutions were made up with neutral or alkaline water.
Fritz et al-, and others at Amchem, clearly considered the pH sensitivity of water solutions of 2-chloroethylphos-phonic acid to be a significant factor in proper use of the acid in accordance with the method of the count. They determined a preferred operating condition well prior to their earliest application filing date. The testimony fully supports the contention herein, and the most exhaustive inspection of the two earliest Fritz et al applications will not locate any reference to the contemplated best mode of carrying out the method of the count.7
Failure to advise potential users of the method of the count, in either of the first two Fritz et al applications, of important preferred operating conditions, i.e., maintaining solutions of 2-chloroethylphos-phonic acid at a pH of less than about 4.5 and using the solutions promptly, constitutes failure to disclose a known best mode, in contravention of the provisions of 35 U.S.C. § 112.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gilbert P. Hyatt v. Gary W. Boone
146 F.3d 1348 (Federal Circuit, 1998)
Upjohn Co. v. Medtron Laboratories, Inc.
751 F. Supp. 416 (S.D. New York, 1990)
American Standard Inc. v. Pfizer Inc.
722 F. Supp. 86 (D. Delaware, 1989)
Fujiie v. Verhagen
887 F.2d 1094 (Federal Circuit, 1989)
Rohm and Haas Co. v. Mobil Oil Corp.
718 F. Supp. 274 (D. Delaware, 1989)
Hybritech Incorporated v. Monoclonal Antibodies, Inc.
802 F.2d 1367 (Federal Circuit, 1986)
Peter J. Degeorge v. Donald R. Bernier
768 F.2d 1318 (Federal Circuit, 1985)
United States Department of Energy v. Daugherty
687 F.2d 438 (Customs and Patent Appeals, 1982)
Tofe v. Winchell
645 F.2d 58 (Customs and Patent Appeals, 1981)
Hester v. Allgeier
646 F.2d 513 (Customs and Patent Appeals, 1981)
Standard Oil Company v. Montedison
494 F. Supp. 370 (D. Delaware, 1980)
Weil v. Fritz
601 F.2d 551 (Customs and Patent Appeals, 1979)
In re Herschler
591 F.2d 693 (Customs and Patent Appeals, 1979)

Cite This Page — Counsel Stack

Bluebook (online)
572 F.2d 856, 196 U.S.P.Q. (BNA) 600, 1978 CCPA LEXIS 342, Counsel Stack Legal Research, https://law.counselstack.com/opinion/weil-v-fritz-ccpa-1978.